• 1
    Butterworth AE, Sturrock RF, Houba D, Mahmoud AAF, Sher A, Rees PH. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 1975;256:7279.
  • 2
    David JR, Butterworth AE, Azevedo de Brito P, et al. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med 1980;303:114752.
  • 3
    Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:15537.
  • 4
    Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:206.
  • 5
    Kimani G, Tonnese MG, Henson PM. Stimulation of eosinophil adherence to vascular endothelial cells in vitro by platelet activating factor. J Immunol 1988;140:31616.
  • 6
    Walsh GM, Hartnell A, Wardlaw AJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:25865.
  • 7
    Håkanson L, Carlson M. Stålenheim G, Venge P. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma. J Allergy Clin Immunol 1990;85:74350.
  • 8
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:17016.
  • 9
    Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:23932400.
  • 10
    Baskar P, Pinkus SH. Selective regulation of eosinophil degranulation by interleukin 1 beta. Proc Soc Exp Biol Med 1992;199:24954.
  • 11
    Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5, and GM-CSF on normal eosinophil and neutrophil C3b-induced degranulation. Allergy 1993;48:43742.
  • 12
    Fujisawa T, Abu-Ghazelah R, Kita H, Sanderson SJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:6426.
  • 13
    Winqvist I, Olofson T, Olsson I. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 1984;51:18.
  • 14
    Sedgwick JB, Vrtis RF, Gourley MF, Busse WW. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol 1988;81:87683.
  • 15
    Shult PA. Graziano FM, Wallow IH, Busse WW. Comparison of superoxide generation and luminol-dependent chemiluminescence with eosinophils and neutrophils from normal individuals. J Lab Clin Med 1985;106:63845.
  • 16
    Lee T Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet activating factor in activated human eosinophils. J Biol Chem 1984;259:552630.
  • 17
    Owen WF Jr, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol 1987;138:5328.
  • 18
    Silberstein DS, Owen WF, Gasson JC, et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol 1986;137:32904.
  • 19
    Carlson M, Håkanson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:2733.
  • 20
    Hansel TT, De-Vries IJ, Iff T, et al. An improved immuno-magnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;1–2:10510.
  • 21
    Reimert CM. Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991;138:28590.
  • 22
    Reimert CM, Minuva U, Kharazmi A, Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN): detection by enzyme-linked immunosorbent assay and purification from normal human urine. J Immunol Methods 1991;141:97104.
  • 23
    Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet activating factor. J Immunol 1994;152:545767.
  • 24
    Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K. Eosinophil degranulation in the presence of bronchial epithelial cells. J Immunol 1996;156:39805.
  • 25
    Hartnell A. Moqbel R, Walsh GM, Bradley B, Kay AB. Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 1990;69:26470.
  • 26
    Bach MK, Brashler JR, Sanders ME, Biemkowski MJ. Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils. J Immunol Methods 1991;142:24350.
  • 27
    Kaneko M, Horie S, Kato M, Gleich GJ, Kita H. A crucial role for β2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1996;155:263141.
  • 28
    Carlson M, Oberg G, Peterson C, Venge P. Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br J Haematol 1994;86:417.
  • 29
    Metcalfe DD, Gadek JE, Raphael GD, Frank MM, Kaplan AP, Kaliner M. Human eosinophil adherence to serum-treated Sepharose: granule-associated enzyme release and requirements of the alternative complement pathway. J Immunol 1977;119:174450.
  • 30
    Peterson CG, Garcia RC, Carlson MGC, Venge P. Eosinophil cationic protein (ECP), eosinophil protein-X (EPX) and eosinophil peroxidase (EPO): granule distribution, degranulation and characterization of released proteins. In: PetersonCGB, editor. Eosinophil granule proteins. Bio-chemical and functional studies. Doctoral thesis, Uppsala University, Sweden, 1987:III, 119.
  • 31
    Anderson DC, Miller LJ, Schmalstieg FC, Rothlein R, Springer TA. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessment employing subunit-specific monoclonal antibodies. J Immunol 1986;137:1527.
  • 32
    Carrera AC, Rincon M, Sanchez-Madrid F, Lopez-Botet M, Delandazuri MO. Triggering of co-mitogenic signals in T-cell proliferation by anti-LFA-1 (CD18, CD11a), LFA3, and CD7 monoclonal antibodies. J Immunol 1988;141:101924.
  • 33
    Egesten A, Gullberg U, Olsson I, Richter J. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins. J Leukoc Biol 1993;53:28793.
  • 34
    Natan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989;109:13419.
  • 35
    Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:37181.
  • 36
    Håkanson L, Søegaard Nielsen L, Teder P. Measurement of neutrophil and eosinophil adhesion to E-selectin, VCAM-1, and ICAM-1 by the use of transfected fibroblast cell lines. J Immunol Methods 1994;176:5366.
  • 37
    Tai P-C, Spry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:1823.
  • 38
    Wardlaw A. Eosinophil density: what does it mean Clin Exp Allergy 1995;25:11459.
  • 39
    Kita H, Horie S, Gleich GJ. Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils. J Immunol 1996;156:117481.